Docstoc

EBREO - Download as DOC

Document Sample
EBREO - Download as DOC Powered By Docstoc
					OSPITAL NG MAYNILA MEDICAL CENTER DEPARTMENT OF INTERNAL MEDICINE

Name: Ebreo, Purificacion Hospital #: 1809346 Address: 1616 3rd St. Fobie Subd. Paco, Manila Age/Sex: 95/F Date of Admission: March 6, 2008 Admitting Diagnosis: CAP, high risk,resolving IHD, HCVD,LVH,NSR,NIF t/c COPD Residents-in-charge: Drs. Filio/Guttierez/Dimaandal/Areja _________________________________________________________________________________________________________________________ Clinical Abstract This is a case of a 95 year old female from Paco, Manila who came in due to difficulty of breathing. History of Present Illness 1 week PTA, patient had a productive cough with yellowish phlegm. There was no fevr, no hemoptysis, no cyanosis,no PND, no orthopnea, no chest pain. The patient self medicated with Cotrimixazole which afforded no relief. Patient eas also given Salbutamol syrup. 3 days PTA, patient had a persistent cough with associated difficulty of breathing. There was no chest pain, no cyanosis, no PND, no hemoptysis hence consulted at Manila Doctors Hospital in which CXR was done revealing hyperaerated lungs, atheromatous aorta, left pleural reaction.The following laboratories were also done: CBC, BUN, Crea, Albumin, Ca, Mg,Na, K, Cl, CK MB, Trop I and sputum exam.The patient was admitted there. Few hours PTA, the patient’s relatives opted to transfer the patient at OMMC. Past Medical History (+)HPN- maintained on Felodipine (-)bronchial asthma (-)DM (-) goiter (-)allergy Family History (-) HPN (-)DM (-) BA (-) allergies. Personal and Social History Non-smoker, non-alcoholic beverage drinker. Review of Systems GENERAL: no weight loss, no chills, no anorexia HEENT: No pain, itchiness, no discharge. No nosebleeding, dryness, obstruction, nor nasal discharge. No gumbleeding, inflammation of the tonsils, soreness, hoarseness. No masses in the neck and difficulty in swallowing. GIT: No changes in bowel, no history of constipation, nor diarrhea. GENITOURINARY: No dysuria, hematuria, or nocturia. No urinary retention, nor incontinence. BREASTS: No discharge, lump, pain, bleeding. ENDOCRINE: No cold/heat intolerance; no sluggishness. No polydipsia, plyuria, and polyphagia. Physical Examination: General: conscious , coherent,not in cardirespiratory distress Vital Signs: BP: 140/80 mmHg HR: 92 bpm RR: 24cpm Temp: 37.1°C Skin: dry skin, no pallor, no yellowish discoloration HEENT: anicteric sclerae, pink palpebral conjunctivae, no nasoaural discharge, no TPC, no CLAD, no distended neck veins CHEST and LUNGS: symmetrical chest expansion, no lagging, no retractions, clear breath sounds HEART: adynamic precordium, PMI at 5th LICS LMCL, normal rate, regular rhythm, no murmur ABDOMEN: flat, normoactive bowel sounds, soft, non-tender Assessment: CAP, high risk,resolving IHD, HCVD,LVH,NSR,NIF t/c COPD Plan: for admission

OSPITAL NG MAYNILA MEDICAL CENTER DEPARTMENT OF INTERNAL MEDICINE

Name: Ebreo, Purificacion Hospital #: 1809346 Address: 1616 3rd St. Fobie Subd. Paco, Manila Age/Sex: 95/F Date of Admission: March 6, 2008 Admitting Diagnosis: CAP, high risk,resolving IHD, HCVD,LVH,NSR,NIF t/c COPD Residents-in-charge: Drs. Filio/Guttierez/Dimaandal/Areja _________________________________________________________________________________________________________________________ 24-HOUR HISTORY This is a case of a 95 year old female from Paco, Manila who came in due to difficulty of breathing. History of Present Illness 1 week PTA, patient had a productive cough with yellowish phlegm. There was no fevr, no hemoptysis, no cyanosis,no PND, no orthopnea, no chest pain. The patient self medicated with Cotrimixazole which afforded no relief. Patient eas also given Salbutamol syrup. 3 days PTA, patient had a persistent cough with associated difficulty of breathing. There was no chest pain, no cyanosis, no PND, no hemoptysis hence consulted at Manila Doctors Hospital in which CXR was done revealing hyperaerated lungs, atheromatous aorta, left pleural reaction.The following laboratories were also done: CBC, BUN, Crea, Albumin, Ca, Mg,Na, K, Cl, CK MB, Trop I and sputum exam.The patient was admitted there. Few hours PTA, the patient’s relatives opted to transfer the patient at OMMC. Past Medical History (+)HPN- maintained on Felodipine (-)bronchial asthma (-)DM (-) goiter (-)allergy Family History (-) HPN (-)DM (-) BA (-) allergies. Personal and Social History Non-smoker, non-alcoholic beverage drinker. Review of Systems GENERAL: no weight loss, no chills, no anorexia HEENT: No pain, itchiness, no discharge. No nosebleeding, dryness, obstruction, nor nasal discharge. No gumbleeding, inflammation of the tonsils, soreness, hoarseness. No masses in the neck and difficulty in swallowing. GIT: No changes in bowel, no history of constipation, nor diarrhea. GENITOURINARY: No dysuria, hematuria, or nocturia. No urinary retention, nor incontinence. BREASTS: No discharge, lump, pain, bleeding. ENDOCRINE: No cold/heat intolerance; no sluggishness. No polydipsia, plyuria, and polyphagia. Physical Examination: General: conscious , coherent,not in cardirespiratory distress Vital Signs: BP: 140/80 mmHg HR: 92 bpm RR: 24cpm Temp: 37.1°C Skin: dry skin, no pallor, no yellowish discoloration HEENT: anicteric sclerae, pink palpebral conjunctivae, no nasoaural discharge, no TPC, no CLAD, no distended neck veins CHEST and LUNGS: symmetrical chest expansion, no lagging, no retractions, clear breath sounds HEART: adynamic precordium, PMI at 5th LICS LMCL, normal rate, regular rhythm, no murmur ABDOMEN: flat, normoactive bowel sounds, soft, non-tender Assessment: CAP, high risk,resolving IHD, HCVD,LVH,NSR,NIF t/c COPD Plan: for admission Course in the wards: Upon admission, patient was placed on low salt, low fat diet with strict aspiration precaution and was hooked to PNSS 1 liter to run for 12 hours. Diagnostics requested include the following: CBC with PC, UA, CXR RBS, ECG,Na, K, Cl, BUN, Crea, FBS, Chole, TG, HDL LDL, sputum GS/CS, 2D Echo. Medications include Levofloxacin 75o mg/tab, 1 tab OD PO, Salbutamol + Ipratropium bromide nebulization q6, Erdosteine 300mg/tab 1 tab TID PO, Simvastatin 200mg/tab 1 tab OD, Captopril 2mg/tab 1 tab TID PO, Diltiazem 3omg/tab 1 tab BID PO, ISDN 5mg/tab 1 tab SL PRN for chest pain, Clopidogrel 75mg/tab 1 tab OD PO,Omeprazole 20mg/tab 1 tab OD PO and Metoclopromide amp, 1 amp TIV PRN for vomiting. Oxygen support was via nasal cannula at 1-3 lpm .Patient was placed on moderate to high back res.Vital signs were monitored q1.

OSPITAL NG MAYNILA MEDICAL CENTER DEPARTMENT OF INTERNAL MEDICINE

Name: Ebreo, Purificacion Hospital #: 1809346 Address: 1616 3rd St. Fobie Subd. Paco, Manila Age/Sex: 95/F Date of Admission: March 6, 2008 Admitting Diagnosis: CAP, high risk,resolving IHD, HCVD,LVH,NSR,NIF t/c COPD Residents-in-charge: Drs. Filio/Guttierez/Dimaandal/Areja _________________________________________________________________________________________________________________________ 48-HOUR HISTORY This is a case of a 95 year old female from Paco, Manila who came in due to difficulty of breathing. History of Present Illness 1 week PTA, patient had a productive cough with yellowish phlegm. There was no fevr, no hemoptysis, no cyanosis,no PND, no orthopnea, no chest pain. The patient self medicated with Cotrimixazole which afforded no relief. Patient eas also given Salbutamol syrup. 3 days PTA, patient had a persistent cough with associated difficulty of breathing. There was no chest pain, no cyanosis, no PND, no hemoptysis hence consulted at Manila Doctors Hospital in which CXR was done revealing hyperaerated lungs, atheromatous aorta, left pleural reaction.The following laboratories were also done: CBC, BUN, Crea, Albumin, Ca, Mg,Na, K, Cl, CK MB, Trop I and sputum exam.The patient was admitted there. Few hours PTA, the patient’s relatives opted to transfer the patient at OMMC. Past Medical History (+)HPN- maintained on Felodipine (-)bronchial asthma (-)DM (-) goiter (-)allergy Family History (-) HPN (-)DM (-) BA (-) allergies. Personal and Social History Non-smoker, non-alcoholic beverage drinker. Review of Systems GENERAL: no weight loss, no chills, no anorexia HEENT: No pain, itchiness, no discharge. No nosebleeding, dryness, obstruction, nor nasal discharge. No gumbleeding, inflammation of the tonsils, soreness, hoarseness. No masses in the neck and difficulty in swallowing. GIT: No changes in bowel, no history of constipation, nor diarrhea. GENITOURINARY: No dysuria, hematuria, or nocturia. No urinary retention, nor incontinence. BREASTS: No discharge, lump, pain, bleeding. ENDOCRINE: No cold/heat intolerance; no sluggishness. No polydipsia, plyuria, and polyphagia. Physical Examination: General: conscious , coherent,not in cardirespiratory distress Vital Signs: BP: 140/80 mmHg HR: 92 bpm RR: 24cpm Temp: 37.1°C Skin: dry skin, no pallor, no yellowish discoloration HEENT: anicteric sclerae, pink palpebral conjunctivae, no nasoaural discharge, no TPC, no CLAD, no distended neck veins CHEST and LUNGS: symmetrical chest expansion, no lagging, no retractions, clear breath sounds HEART: adynamic precordium, PMI at 5th LICS LMCL, normal rate, regular rhythm, no murmur ABDOMEN: flat, normoactive bowel sounds, soft, non-tender Assessment: CAP, high risk,resolving IHD, HCVD,LVH,NSR,NIF t/c COPD Plan: for admission Course in the wards: Upon admission, patient was placed on low salt, low fat diet with strict aspiration precaution and was hooked to PNSS 1 liter to run for 12 hours. Diagnostics requested include the following: CBC with PC, UA, CXR RBS, ECG,Na, K, Cl, BUN, Crea, FBS, Chole, TG, HDL LDL, sputum GS/CS, 2D Echo. Medications include Levofloxacin 75o mg/tab, 1 tab OD PO, Salbutamol + Ipratropium bromide nebulization q6, Erdosteine 300mg/tab 1 tab TID PO, Simvastatin 200mg/tab 1 tab OD, Captopril 2mg/tab 1 tab TID PO, Diltiazem 3omg/tab 1 tab BID PO, ISDN 5mg/tab 1 tab SL PRN for chest pain, Clopidogrel 75mg/tab 1 tab OD PO,Omeprazole 20mg/tab 1 tab OD PO and Metoclopromide amp, 1 amp TIV PRN for vomiting. Oxygen support was via nasal cannula at 1-3 lpm .Patient was placed on moderate to high back res.Vital signs were monitored q1. On the 2nd hospital day, repeat chest x-ray was requested and done. Other results of laboratories requested were noted. Patient was stable hence vital signs were monitored every 4 hours.

OSPITAL NG MAYNILA MEDICAL CENTER DEPARTMENT OF INTERNAL MEDICINE

Name: Ebreo, Purificacion Hospital #: 1809346 Address: 1616 3rd St. Fobie Subd. Paco, Manila Age/Sex: 95/F Date of Admission: March 6, 2008 Admitting Diagnosis: CAP, high risk,resolving IHD, HCVD,LVH,NSR,NIF t/c COPD Residents-in-charge: Drs. Filio/Guttierez/Dimaandal/Areja _________________________________________________________________________________________________________________________ Patient Discharge Summary his is a case of a 95 year old female from Paco, Manila who came in due to difficulty of breathing. History of Present Illness 1 week PTA, patient had a productive cough with yellowish phlegm. There was no fevr, no hemoptysis, no cyanosis,no PND, no orthopnea, no chest pain. The patient self medicated with Cotrimixazole which afforded no relief. Patient eas also given Salbutamol syrup. 3 days PTA, patient had a persistent cough with associated difficulty of breathing. There was no chest pain, no cyanosis, no PND, no hemoptysis hence consulted at Manila Doctors Hospital in which CXR was done revealing hyperaerated lungs, atheromatous aorta, left pleural reaction.The following laboratories were also done: CBC, BUN, Crea, Albumin, Ca, Mg,Na, K, Cl, CK MB, Trop I and sputum exam.The patient was admitted there. Few hours PTA, the patient’s relatives opted to transfer the patient at OMMC. Past Medical History (+)HPN- maintained on Felodipine (-)bronchial asthma (-)DM (-) goiter (-)allergy Family History (-) HPN (-)DM (-) BA (-) allergies. Personal and Social History Non-smoker, non-alcoholic beverage drinker. Review of Systems GENERAL: no weight loss, no chills, no anorexia HEENT: No pain, itchiness, no discharge. No nosebleeding, dryness, obstruction, nor nasal discharge. No gumbleeding, inflammation of the tonsils, soreness, hoarseness. No masses in the neck and difficulty in swallowing. GIT: No changes in bowel, no history of constipation, nor diarrhea. GENITOURINARY: No dysuria, hematuria, or nocturia. No urinary retention, nor incontinence. BREASTS: No discharge, lump, pain, bleeding. ENDOCRINE: No cold/heat intolerance; no sluggishness. No polydipsia, plyuria, and polyphagia. Physical Examination: General: conscious , coherent,not in cardirespiratory distress Vital Signs: BP: 140/80 mmHg HR: 92 bpm RR: 24cpm Temp: 37.1°C Skin: dry skin, no pallor, no yellowish discoloration HEENT: anicteric sclerae, pink palpebral conjunctivae, no nasoaural discharge, no TPC, no CLAD, no distended neck veins CHEST and LUNGS: symmetrical chest expansion, no lagging, no retractions, clear breath sounds HEART: adynamic precordium, PMI at 5th LICS LMCL, normal rate, regular rhythm, no murmur ABDOMEN: flat, normoactive bowel sounds, soft, non-tender Assessment: CAP, high risk,resolving IHD, HCVD,LVH,NSR,NIF t/c COPD Plan: for admission Course in the wards: Upon admission, patient was placed on low salt, low fat diet with strict aspiration precaution and was hooked to PNSS 1 liter to run for 12 hours. Diagnostics requested include the following: CBC with PC, UA, CXR RBS, ECG,Na, K, Cl, BUN, Crea, FBS, Chole, TG, HDL LDL, sputum GS/CS, 2D Echo. Medications include Levofloxacin 75o mg/tab, 1 tab OD PO, Salbutamol + Ipratropium bromide nebulization q6, Erdosteine 300mg/tab 1 tab TID PO, Simvastatin 200mg/tab 1 tab OD, Captopril 2mg/tab 1 tab TID PO, Diltiazem 3omg/tab 1 tab BID PO, ISDN 5mg/tab 1 tab SL PRN for chest pain, Clopidogrel 75mg/tab 1 tab OD PO,Omeprazole 20mg/tab 1 tab OD PO and Metoclopromide amp, 1 amp TIV PRN for vomiting. Oxygen support was via nasal cannula at 1-3 lpm .Patient was placed on moderate to high back res.Vital signs were monitored q1. On the 2nd hospital day, repeat chest x-ray was requested and done. Other results of laboratories requested were noted. Oxygen support was via nasal cannula at 1-3 lpm . Patient was stable hence vital signs were monitored every 4 hours. On the 3rd hospital day , diet was maintained with strict aspiration precaution. IVF was PNSS 1 L x 12 hours. CXR was done. Other present medications were continued. Oxygen support was via nasal cannula at 1-3 lpm . Patient was placed on moderate to high back rest. Vital signs were monitored evey 4 hours. On the 4th hospital day ,NGT was inserted and Oral feeding of 2100 kcal/day divided into 5 equal feedings was started. IVF was D5NM 1L x 12hours. ABG was done.Leveofloxacin was shifted to Pip Tazo 25 gm IV q6. Other present medications were continued. Oxygen support was via nasal cannula at 1-3 lpm . Patient was placed on moderate to high back rest. Vital signs were monitored every 4 hours. On the 5th hospital day ,NGT and Oral feeding were maintained.IVF was D5NM 1L x 12hours. Other present medications were continued. Oxygen support was via nasal cannula at 1-3 lpm . Patient was placed on moderate to high back rest. Vital signs were monitored evey 4 hours.

On the 6th hospital day ,NGT and Oral feeding were maintained.IVF was D5NM 1L x 12hours.Serum K and urinalysis were done. KCL tablet 2 tablets q4 per NGT was started. PIpTazo was shifted to IMipenem 1 gm TIV q12 ANST. Other present medications were continued. Oxygen support was via nasal cannula at 1-3 lpm . Patient was placed on moderate to high back rest. Vital signs were monitored every 4 hours. On the 7th hospital day, patient was continued on oral feeding via NGT. Medications were continued and was placed on moderate high back rest. Patient was with oxygen support. On the 8th hospital day NGT was recommended to be removed and soft feeding started if tolerated. IVF PNSS 1Lx40mEqs was maintained. All present medications were continued. Diagnostics requested included the ff: Serum Ca, Mg; sputum gs/cs; sputum AFBx3 days. Oxygen support was shifted from NC to facial mask at 10lpm. CBG postprandial q12 was ordered as well as I and O monitoring. On the 9th hospital day, patient tolerates oral feeding. IVF was D5NM 1L x 12hours. Chest X-ray, CBC, ABG’s were done. Previous medications were continued. Patient was mainatained in a moderate-high back rest vital signs were monitored every 4 hours. On the 10th hospital day, IVF was D5NM 1L x 12hours. Previous medications were continued. Patient was started on Acetylcysteine 200mg IV on ½ ml water taked three times a day. Patient was still maintained on high back rest. Oxygen support was given. On the 11th hospital day, IVF was D5NM 1L x 12hours ABG, serum K was done. Patient was maintained on previous medications. Antiembolic stockings was done at both lower extremities. Patient was encouraged sitiing up. Patient was stable because vital signs were monitored every 4 hours. On the 12th hospital day, IVF was D5NM 1L x 12hours. Medications were continued. Patient was placed on moderate back rest and maintained with anti-embolic stockings. Vital signs were stable.

Piperacilin Tazobactam

Erdosteine

Muco-modulatory activity, antibacterial activity, antiinflammatory activity, antioxidant activity

Treatment of infections in the lower resp tract eg severe communityaquired pneumonia & healthcare pneumonia; uncomplicated & complicated skin & skin structure infections; intra-abdominal infections w/ peritonitis eg complicated appendicitis; complicated & uncomplicated UTI; gynecologic infection eg postpartum endometritis or pelvic inflammatory disease; bacterial infection in neutropenic patients; bone & joint infections; bacterial sepsis. Acute bronchitis, chronic bronchitis & its exacerbations. Resp disorders characterised by abnormal bronchial secretions & impaired mucus transport. Treatment of hypertension, heart failure, prophylaxis in the management of myocardial infarction, management of hypertension in diabetic nephropathy in type i diabetes

2.25mg IV q6h

Hypersensitivity to penicillins, cephalosporins & βlactam inhibitors.

Rash, pruritus, fever; diarrhea, nausea, constipation, vomiting, dyspepsia, stool changes, abdominal pain, transient leucopenia, neutropenia, thrombocytopenia; hepatic & renal effects; headache, insomnia, agitation, dizziness, anxiety; HTN, chest pain, edema, moniliasis, rhinitis, dyspnea, hypotension, ileus, syncope, rigors, phlebitis, pain, inflammation, thrombophlebitis. No gastrointestinal nor systemic side effects

Vial 2g/250mg x 1's 4g/500mg x 1's

1 cap TID

Hepatic cirrhosis & cystathioninesynthetase enzyme deficiency

Cap 300 mg Susp 175 mg/5 mL x 60 mL, 100 mL.

Captopril

Simvastatin

Clopidogrel

Competitively inhibits the conversion of angiotensin I (ATI) to angiotensin II (ATII), thus resulting in reduced ATII levals and aldosterone secretion. It also increases plasma renin activity and bradykinin levels. Reduction of ATII leads to decreased Na and water retention Inhibits the conversion of HMGCoA to mevalonic acid by blocking the enzyme HMG-CoA reductase, an early and rate-limiting step in cholesterol biosynthesis. Simvastatin has been demonstrated to reduce total cholesterol, LDLcholesterol and triglycerides and increase HDLcholesterol levels. Inhibits adenosine diphosphate (ADP) from binding to its receptor sites on the

25 mg ½ tab TID

Known hypersensitivity to the drug. Bilateral renal artery stenosis, hereditary angioedema; renal impairment; pregnancy.

Hypotension, tachycardia, chest pain, palpitations, pruritus, hyperkalaemia. Proteinuria; angioedema, skin rashes; taste disturbance, nonproductive cough, headache.

25mg tab

treatment of hypercholesterolaemia (types iia and iib), hyperlipoproteinaemias

20mg OD HS

Hypersensitivity; acute liver disease or unexplained persistent elevations of serum transaminases. Pregnancy, lactation.

Headache, nausea, flatulence, heartburn, abdominal pain, diarrhoea/constipation, dysgeusia; myopathy features like myalgia and muscle weakness; serum transaminases and CPK elevations; hypersensitivity; lens opacities; blurring of vision; dizziness; sexual dysfunction; insomnia; depression and upper resp symptoms. Dyspepsia, abdominal pain, nausea, vomiting, flatulence, constipation, gastritis,

Tab 10mg, 20mg, 40mg, 80mg

prophylaxis in thromboembolic disorders including myocardial infarction,

75mg OD

Hypersensitivity. Active pathological bleeding. admin w/in 7 days after MI and

Tab 75mg

Omeprazole

platelets and subsequent activation of glycoprotein GP IIb/IIIa complex thus preventing fibrinogen binding, platelet adhesion and aggregation. Inhibits the release of H ions to the stomach by antagonizing the H-K ATPase (proton pump) of the parietal cells.

peripheral arterial disease and stroke

ischaemic stroke, coagulation disorders. Lactation.

gastric and duodenal ulcers. GI upset, diarrhoea, paraesthesia, vertigo, headache, dizziness, pruritus and rashes. Headache, rarely rash, pruritus, paresthesia, somnolence, insomnia, vertigo, diarrhea, constipation, nausea, vomiting, flatulence, increased liver enzymes, malaise, hypersensitivity reactions Cap 10, 40mg Vial 40mg x 10 mL

Duodenal ulcer, gastric ulcer and GERD, Dyspepsia, Aspiration prophylaxis, ZillingerEllison Syndrome.

20mg BID

May prolong elimination of diazepam, warfarin, phenytoin, increases the plasma concentration of clarithromycin.

Salbutamol Ipratropium

Management of reversible bronchospasm associated w/ obstructive airway diseases in patients who require more than a single bronchodilator. Inhibits the H1 receptor, anti-emetic GI motility, nausea, vomiting of central and peripheral origin assoc. with surgery, infectious diseases and drug use. Poor appetite, underwt, anorexia nervosa. For nutritional support in post-op cases, metabolic disorders & convalescence.

q4

Metoclopramide

10mg q8

Hypertrophic obstructive cardiomyopathy or tachyarrhythmia. History of hypersensitivity to soya lecithin or related food products (for MDI only) Intestinal obstruction

Fine tremor of skeletal muscle; palpitations; headache, dizziness, nervousness; dryness of mouth, throat irritation; urinary retention. Extrapyramidal reactions, drowsiness, fatigue, dizziness Drowsiness & dulling of mental alertness, dry mouth, headache, nausea, jitteriness, tiredness. Flushing, vascular headache, cerebral ischemia associated w/ postural hypotension, nausea, vomiting, weakness, restlessness, pallor, perspiration & collapse; drug rash &/or exfoliative dermatitis.

2.5ml unit dose vial

Tab 10 mg Amp 10mg/2ml Syrup 5mg/5mL x 60 mL

Multivitamins + Buclizine

I tab OD

Angle closure glaucoma, prostatic hypertrophy & primary hemochromatosis. Tolerance & crosstolerance to other nitrates & nitrites may occur. Pregnancy, lactation, childn. Patients prone to or affected by hypotension or vol depletion; severe hypotensive response; paradoxical bradycardia, increased angina may accompany nitrate induced hypotension, hypertrophic cardiomyopathy. None

100mg tab

ISDN

5mg PRN for pain

Paracetamol

Analgesic & antipyretic

Relief of fever, minor aches & pains

1 ½ tab

Allergic skin reactions

Amp 150mg/1mL x 2 mL

CBC WBC RBC Hgb Hct MCV MCH MCHC Platelet Neutrophils Lymphocytes Monocytes Eosinophils Basophils Normal Values 4.8-10.8 x 109 /L 4.0-6.20 x 1012 /L 12-16g/dl 37-47 % 80-90 fL 27-31 32-36 150-400 x 10^9/L 55-57 20-30% 0-7% 0-3% 0-1% Urinalysis Color Transparency pH Sp garvity Mucus threads Pus Cells Sugar Albumin Bacteria Epithelial cells Urine Potassium Urine Sodium

-

26.7 (NV: 12.00-75.00) 125 (NV: 20-110.00)

Blood Chemistry
BUN Creatinine Sodium Potassium Chloride HDL Triglycerides Glucose Cholesterol LDL BUA LDH SGOT SGPT Alk. Phos Total Protein Albumin Serum Globulin CKMB ABG Test pH pCO2 pO2 HC03 TC02 BEb O2St Normal Values 1.7 - 8.3 mmol/L 59-104 umol/L 140-148 mmol/L 3.6 – 5.2 mmol/L 100 – 108 mmol/L 0.91-1.56 0.34-1.70 3.90-6.10 4.20-5.20 1.10-3.80 0.11-0.43 100-190 15-37 U/L 30-65 U/L 35-129U/L 66-87g/l 34-48g/l 20-38 g/l 0.00 - 16 03/06

0.17 2.64


				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:7
posted:7/4/2009
language:
pages:9